Status:
COMPLETED
MMP-9 Expression in Permanent Mature Teeth With Symptomatic Pulpitis
Lead Sponsor:
Eglė Gvazdaitytė
Conditions:
Pulpitis
Eligibility:
All Genders
14-33 years
Phase:
NA
Brief Summary
Matrix metallopeptidase-9 (MMP-9) expression was compared in healthy and inflamed pulp and the outcome of coronal pulpotomy in teeth with symptomatic pulpitis was assessed. After procedure blood sampl...
Detailed Description
Introduction: Widely used diagnostic tests do not provide information to distinguish the pulp inflammation stage while improvement of materials, techniques and vital pulp therapy have received a wider...
Eligibility Criteria
Inclusion
- Teeth diagnosed with symptomatic pulpitis
- Patients who did not use any NSAIDs before the treatment
- Positive cold test of investigated teeth
- Clinically dental caries in contact with pulp chamber
- Permanent teeth with radiographically closed root apex
Exclusion
- Patients who refuse to participate in the study
- Medically compromised patients (with immunosuppressive/systemic diseases, patients on medications)
- Teeth with periapical radiolucency or clinical signs of apical periodontitis
- Periodontological compromised teeth (probing depth ≥4mm)
- Internal/external root resorption in periapical radiograph
- Pulp chamber and/or root canal calcification in periapical radiograph
- Teeth with unrestorable crown
- Teeth with a negative response to cold test
Key Trial Info
Start Date :
March 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 11 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03807674
Start Date
March 27 2017
End Date
February 11 2018
Last Update
January 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lithuanian University of Health Science
Kaunas, Lithuania